Patent Assignment
Reel/Frame 047083/0920
Assignment of Assignor's Interest
Recorded: 2018-10-05
Pages: 9
Assignor
CENTREXION I, INC.
Executed: 2015-07-27
Assignee
CENTREXION THERAPEUTICS CORPORATION
509 SOUTH EXETER STREET, SUITE 202, BALTIMORE, MARYLAND, 21202
Covered Property
(1)
Injectable Resiniferatoxin
Application:
15/363,475 →
Publication:
US 2017/0266139
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Oct 5, 2018
From: VALLINEX, INC.
To: CENTREXION I, INC.
Reel/Frame 047083/0784 →
Assignment of Assignor's Interest
Oct 5, 2018
From: BURCH, RONALD M.; CARTER, RICHARD B.; LAZAR, JEFFREY D.
To: ALGORX PHARMACEUTICALS, INC.
Reel/Frame 047083/0817 →
Assignment of Assignor's Interest
Oct 5, 2018
From: ARCION THERAPEUTICS, INC.
To: VALLINEX, INC.
Reel/Frame 047083/0837 →
Assignment of Assignor's Interest
Oct 5, 2018
From: ALGORX PHARMACEUTICALS, INC.; ANESIVA INC.
To: ARCION THERAPEUTICS, INC.
Reel/Frame 047084/0156 →
Security Interest
Jul 12, 2023
From: CENTREXION THERAPEUTICS CORPORATION
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P., AS AGENT
Reel/Frame 064256/0125 →
Release of Security Interest
Nov 21, 2025
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P., AS AGENT
To: CENTREXION THERAPEUTICS CORPORATION
Reel/Frame 073683/0099 →